Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2017 02:22 ET | Source: Probiodrug

Last Patient Last Visit (LPLV) reached in the SAPHIR Study

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Last Patient Last Visit (LPLV) reached...
April 03, 2017 01:00 ET | Source: Probiodrug

Probiodrug to attend International Conferences in April 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Probiodrug to attend International...
March 30, 2017 01:00 ET | Source: Probiodrug

Probiodrug reports full year 2016 financial results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Probiodrug reports full year 2016...
March 28, 2017 01:00 ET | Source: Probiodrug

Probiodrug to present at Alzheimer's and Parkinson's Diseases Congress

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Probiodrug to present at...
March 23, 2017 02:00 ET | Source: Probiodrug

Probiodrug AG to Publish its Full Year 2016 Results on 30 March 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Probiodrug AG to Publish its Full...
March 06, 2017 01:00 ET | Source: Probiodrug

Probiodrug to attend and present at International Conferences in March 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Probiodrug to attend and present at...
February 02, 2017 01:00 ET | Source: Probiodrug

Probiodrug to attend and present at International Conferences in February 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Probiodrug to attend and present at...
January 09, 2017 01:00 ET | Source: Probiodrug

Probiodrug announces completion of recruitment for the SAPHIR Phase 2a study of Glutaminyl Cyclase Inhibitor PQ912 in early Alzheimer's disease patients

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Probiodrug announces completion of...
January 04, 2017 01:00 ET | Source: Probiodrug

Probiodrug to attend International Conferences in January 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Probiodrug to attend International...
December 08, 2016 01:00 ET | Source: Probiodrug

Probiodrug: Innovative Phase II study design of Glutaminylcyclase Inhibitor PQ912 in early Alzheimer's disease

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Innovative Phase II study design of...